Stock market today: S&P 500 drops for fifth day as focus shifts to Powell’s speech
Investing.com - AngioDynamics (NASDAQ: ANGO) reported third quarter EPS of $0.03, $0.14 better than the analyst estimate of $-0.11. Revenue for the quarter came in at $72M versus the consensus estimate of $70.57M.
Guidance
AngioDynamics sees FY 2025 EPS of $-0.31 versus the analyst consensus of $-0.35.
AngioDynamics sees FY 2025 revenue of $285.00M-$288.00M versus the analyst consensus of $284.90M.
AngioDynamics’s stock price closed at $9.66. It is up 6.39% in the last 3 months and up 58.88% in the last 12 months.
AngioDynamics saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See AngioDynamics’s stock price’s past reactions to earnings here.
According to InvestingPro, AngioDynamics’s Financial Health score is "fair performance".
Check out AngioDynamics’s recent earnings performance, and AngioDynamics’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar